ARCHIVES

Report Backs EPA Classification of PERC as Likely Human Carcinogen

This article is from The Cancer Letter archive.

Vol. 36 No. 05 | February 12, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

April 29, 1988

HHS, NIH To Help Houston Rebuild Research Facilities.

July 13, 2001

SWOG Plans Increase in Payments to Centers for Trial Accrual.

May 25, 2007

In Brief: BRI Gets New FCRF Basic Research Contract; Senate Subcommittee Less Generous Than House

October 2, 1987

In Brief: Healy Nominated to Head NIH; Hammond, D’Angio To Step Down as Group Chairman

January 18, 1991

NCA Approves Draft of New Outstanding Investigator Grants

February 10, 1984